Company Search:
Advanced Search
Sponsored Links
Xiangxue Pharmaceutical Co Ltd Company Snapshot
Xiangxue Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Xiangxue Pharmaceutical Co Ltd with three other companies in this sector in CHINA : Guizhou Bailing Group Pharmaceutical Company Limited (2019 sales of 2.85 billion Chinese Renmimbi [US$417.72 million] of which 84% was Industry), Mayinglong Pharmaceutical Group Co Ltd (2.70 billion Chinese Renmimbi [US$396.33 million] of which 54% was Pharmaceutical Industry), and Sihuan Pharmaceutical Holdings Group Ltd (2.89 billion Chinese Renmimbi [US$423.06 million] of which 100% was Manufaturing and Sale of Pharmaceutical ).

Sales Analysis. During the year ended December of 2019, sales at Xiangxue Pharmaceutical Co Ltd were 2.79 billion Chinese Renmimbi (US$408.29 million). This is an increase of 11.3% versus 2018, when the company's sales were 2.50 billion Chinese Renmimbi. This was the fourth straight year of sales growth at Xiangxue Pharmaceutical Co Ltd. Sales of Chinese Herbal Medicines saw an increase that was more than double the company's growth rate: sales were up 46.3% in 2019, from 924.85 million Chinese Renmimbi to 1.35 billion Chinese Renmimbi. Xiangxue Pharmaceutical Co Ltd also saw significant increases in sales in Pharmaceutical Manufacturing (up 32.9% to 767.81 million Chinese Renmimbi) . Not all segments of Xiangxue Pharmaceutical Co Ltd experienced an increase in sales in 2019: sales of Medical Apparatus and Instruments fell 6.0% to 15.83 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Xiangxue Pharmaceutical Co Ltd
  Stock Performance Chart for Xiangxue Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 11.04
(Figures in Chinese Renmimbi)
1 Week -10.1%   13 Weeks 4.9%  
4 Weeks 16.1%   52 Weeks 77.5%  
Xiangxue Pharmaceutical Co Ltd Key Data:
  Ticker: 300147 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 2,786,199,517
(Year Ending Jan 2020).
Employees: 2,808
  Currency: Chinese Renmimbi Market Cap: 7,302,698,738
  Fiscal Yr Ends: December Shares Outstanding: 661,476,335
  Share Type: A Gu Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.